Effects of neurotropin in patients with hereditary spino-cerebellar degeneration.
J
J
Van Mullem
D000276:Adjuvants, Immunologic / Q000627:therapeutic use; D000700:Analgesics / Q000627:therapeutic use*; D006801:Humans; D011134:Polysaccharides / Q000627:therapeutic use*; D013132:Spinocerebellar Degenerations / Q000188:drug therapy*
D000276:Adjuvants, Immunologic; D000700:Analgesics; D011134:Polysaccharides; C010491:neurotropin